Annual CFF
-$3.64 M
-$10.36 M-154.12%
31 December 2023
Summary:
Imunon annual cash flow from financing activities is currently -$3.64 million, with the most recent change of -$10.36 million (-154.12%) on 31 December 2023. During the last 3 years, it has fallen by -$21.62 million (-120.23%). IMNN annual CFF is now -106.64% below its all-time high of $54.77 million, reached on 31 December 2021.IMNN Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$9.06 M
+$9.06 M+100.00%
30 September 2024
Summary:
Imunon quarterly cash flow from financing activities is currently $9.06 million, with the most recent change of +$9.06 million (+100.00%) on 30 September 2024. Over the past year, it has increased by +$8.99 million (+11475.61%). IMNN quarterly CFF is now -77.60% below its all-time high of $40.46 million, reached on 01 March 2021.IMNN Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$9.09 M
+$8.99 M+8281.47%
30 September 2024
Summary:
Imunon TTM cash flow from financing activities is currently $9.09 million, with the most recent change of +$8.99 million (+8281.47%) on 30 September 2024. Over the past year, it has increased by +$12.32 million (+382.30%). IMNN TTM CFF is now -84.14% below its all-time high of $57.33 million, reached on 01 September 2021.IMNN TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IMNN Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -154.1% | +10000.0% | +382.3% |
| 3 y3 years | -120.2% | +10000.0% | -84.1% |
| 5 y5 years | -134.4% | +429.6% | +56.9% |
IMNN Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -106.6% | at low | at high | +245.7% | -84.1% | +248.8% |
| 5 y | 5 years | -106.6% | at low | -77.6% | +245.7% | -84.1% | +248.8% |
| alltime | all time | -106.6% | at low | -77.6% | +245.7% | -84.1% | +248.8% |
Imunon Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $9.06 M(>+9900.0%) | $9.09 M(+8281.5%) |
| June 2024 | - | $0.00(0.0%) | $108.50 K(-101.8%) |
| Mar 2024 | - | $0.00(-100.0%) | -$6.11 M(+68.0%) |
| Dec 2023 | -$3.64 M(-154.1%) | $30.20 K(-61.4%) | -$3.64 M(+12.9%) |
| Sept 2023 | - | $78.30 K(-101.3%) | -$3.22 M(-4.2%) |
| June 2023 | - | -$6.22 M(-351.4%) | -$3.36 M(-136.6%) |
| Mar 2023 | - | $2.47 M(+453.2%) | $9.20 M(+36.8%) |
| Dec 2022 | $6.72 M(-87.7%) | $447.30 K(-798.9%) | $6.72 M(+7.1%) |
| Sept 2022 | - | -$64.00 K(-101.0%) | $6.28 M(-0.9%) |
| June 2022 | - | $6.34 M(>+9900.0%) | $6.33 M(-55.8%) |
| Mar 2022 | - | $0.00(0.0%) | $14.31 M(-73.9%) |
| Dec 2021 | $54.77 M(+204.5%) | - | - |
| Dec 2021 | - | $0.00(-100.0%) | $54.77 M(-4.5%) |
| Sept 2021 | - | -$8300.00(-100.1%) | $57.33 M(+5.8%) |
| June 2021 | - | $14.32 M(-64.6%) | $54.21 M(+3.0%) |
| Mar 2021 | - | $40.46 M(+1479.6%) | $52.65 M(+192.7%) |
| Dec 2020 | $17.98 M(+129.2%) | $2.56 M(-181.8%) | $17.98 M(+5.2%) |
| Sept 2020 | - | -$3.13 M(-124.5%) | $17.09 M(-22.1%) |
| June 2020 | - | $12.76 M(+120.2%) | $21.94 M(+84.6%) |
| Mar 2020 | - | $5.79 M(+247.1%) | $11.88 M(+51.5%) |
| Dec 2019 | $7.84 M(-25.9%) | $1.67 M(-2.5%) | $7.84 M(+35.3%) |
| Sept 2019 | - | $1.71 M(-36.8%) | $5.80 M(+41.9%) |
| June 2019 | - | $2.71 M(+54.4%) | $4.09 M(-63.2%) |
| Mar 2019 | - | $1.75 M(-564.1%) | $11.10 M(+4.9%) |
| Dec 2018 | $10.58 M(-71.0%) | -$378.10 K(<-9900.0%) | $10.58 M(-71.1%) |
| Sept 2018 | - | $0.00(-100.0%) | $36.68 M(-10.2%) |
| June 2018 | - | $9.72 M(+686.4%) | $40.84 M(+18.8%) |
| Mar 2018 | - | $1.24 M(-95.2%) | $34.37 M(-5.7%) |
| Dec 2017 | $36.45 M(+1261.4%) | $25.72 M(+517.8%) | $36.45 M(+231.0%) |
| Sept 2017 | - | $4.16 M(+27.9%) | $11.01 M(+89.5%) |
| June 2017 | - | $3.26 M(-1.8%) | $5.81 M(-16.8%) |
| Mar 2017 | - | $3.32 M(+1092.6%) | $6.98 M(+160.8%) |
| Dec 2016 | $2.68 M(-34.4%) | $278.10 K(-126.7%) | $2.68 M(+32.6%) |
| Sept 2016 | - | -$1.04 M(-123.5%) | $2.02 M(-1.4%) |
| June 2016 | - | $4.43 M(-548.0%) | $2.05 M(-48.4%) |
| Mar 2016 | - | -$988.50 K(+160.2%) | $3.97 M(-2.7%) |
| Dec 2015 | $4.08 M(-78.3%) | -$379.90 K(-62.4%) | $4.08 M(-8.5%) |
| Sept 2015 | - | -$1.01 M(-115.9%) | $4.46 M(-18.5%) |
| June 2015 | - | $6.35 M(-823.1%) | $5.47 M(+34.0%) |
| Mar 2015 | - | -$878.40 K(<-9900.0%) | $4.09 M(-78.2%) |
| Dec 2014 | $18.78 M(-36.1%) | $0.00(0.0%) | $18.78 M(-2.5%) |
| Sept 2014 | - | $0.00(-100.0%) | $19.26 M(+2.5%) |
| June 2014 | - | $4.96 M(-64.1%) | $18.79 M(-16.2%) |
| Mar 2014 | - | $13.81 M(+2790.0%) | $22.42 M(-23.7%) |
| Dec 2013 | $29.39 M(+89.4%) | $478.00 K(-201.7%) | $29.39 M(-17.9%) |
| Sept 2013 | - | -$470.20 K(-105.5%) | $35.78 M(-10.8%) |
| June 2013 | - | $8.60 M(-58.6%) | $40.13 M(+10.4%) |
| Mar 2013 | - | $20.78 M(+202.4%) | $36.35 M(+134.2%) |
| Dec 2012 | $15.52 M(-70.6%) | $6.87 M(+77.3%) | $15.52 M(-31.3%) |
| Sept 2012 | - | $3.88 M(-19.5%) | $22.59 M(-46.3%) |
| June 2012 | - | $4.82 M(<-9900.0%) | $42.09 M(-12.1%) |
| Mar 2012 | - | -$46.30 K(-100.3%) | $47.89 M(-9.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | $52.84 M(+2123.6%) | $13.94 M(-40.4%) | $52.84 M(+32.2%) |
| Sept 2011 | - | $23.37 M(+120.0%) | $39.98 M(+122.7%) |
| June 2011 | - | $10.62 M(+116.9%) | $17.95 M(+145.9%) |
| Mar 2011 | - | $4.90 M(+353.6%) | $7.30 M(+207.2%) |
| Dec 2010 | $2.38 M(-61.0%) | $1.08 M(-20.0%) | $2.38 M(+86.0%) |
| Sept 2010 | - | $1.35 M(-5171.1%) | $1.28 M(-79.7%) |
| June 2010 | - | -$26.60 K(+3.1%) | $6.28 M(+0.5%) |
| Mar 2010 | - | -$25.80 K(+35.1%) | $6.25 M(+2.5%) |
| Dec 2009 | $6.10 M(-1001.1%) | -$19.10 K(-100.3%) | $6.10 M(+2.6%) |
| Sept 2009 | - | $6.35 M(<-9900.0%) | $5.95 M(-1127.6%) |
| June 2009 | - | -$59.10 K(-66.3%) | -$578.60 K(-15.8%) |
| Mar 2009 | - | -$175.60 K(+1.3%) | -$687.00 K(+1.5%) |
| Dec 2008 | -$676.90 K(-60.8%) | -$173.40 K(+1.7%) | -$676.80 K(-79.5%) |
| Sept 2008 | - | -$170.50 K(+1.8%) | -$3.30 M(+60.5%) |
| June 2008 | - | -$167.50 K(+1.3%) | -$2.06 M(+8.9%) |
| Mar 2008 | - | -$165.40 K(-94.1%) | -$1.89 M(+9.6%) |
| Dec 2007 | -$1.72 M(-119.2%) | -$2.80 M(-360.5%) | -$1.72 M(-260.5%) |
| Sept 2007 | - | $1.07 M(>+9900.0%) | $1.07 M(-76.1%) |
| June 2007 | - | $0.00(0.0%) | $4.50 M(0.0%) |
| Mar 2007 | - | $0.00(0.0%) | $4.50 M(-50.0%) |
| Dec 2006 | $9.00 M(+50.0%) | $0.00(-100.0%) | $9.00 M(0.0%) |
| Sept 2006 | - | $4.50 M(>+9900.0%) | $9.00 M(-14.3%) |
| June 2006 | - | $0.00(-100.0%) | $10.50 M(0.0%) |
| Mar 2006 | - | $4.50 M(>+9900.0%) | $10.50 M(+75.0%) |
| Dec 2005 | $6.00 M(-53.3%) | $0.00(-100.0%) | $6.00 M(0.0%) |
| Sept 2005 | - | $6.00 M(>+9900.0%) | $6.00 M(>+9900.0%) |
| June 2005 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2005 | - | $0.00(0.0%) | $2.81 M(-78.1%) |
| Dec 2004 | $12.84 M(-34.8%) | $0.00(0.0%) | $12.84 M(-22.9%) |
| Sept 2004 | - | $0.00(-100.0%) | $16.64 M(-34.5%) |
| June 2004 | - | $2.81 M(-72.0%) | $25.41 M(-5.8%) |
| Mar 2004 | - | $10.03 M(+163.6%) | $26.98 M(+25.6%) |
| Dec 2003 | - | $3.81 M(-56.6%) | $21.48 M(+9.2%) |
| Sept 2003 | $19.68 M(+158.0%) | $8.77 M(+100.5%) | $19.68 M(+80.1%) |
| June 2003 | - | $4.37 M(-3.6%) | $10.93 M(+27.3%) |
| Mar 2003 | - | $4.54 M(+126.6%) | $8.58 M(+45.0%) |
| Dec 2002 | - | $2.00 M(>+9900.0%) | $5.92 M(-22.4%) |
| Sept 2002 | $7.63 M(>+9900.0%) | $14.00 K(-99.3%) | $7.63 M(+2.5%) |
| June 2002 | - | $2.03 M(+8.0%) | $7.44 M(+35.1%) |
| Mar 2002 | - | $1.88 M(-49.4%) | $5.51 M(+47.0%) |
| Dec 2001 | - | $3.71 M(-2279.2%) | $3.75 M(+9818.0%) |
| Sept 2001 | $37.70 K(-99.7%) | -$170.30 K(-282.9%) | $37.80 K(-112.7%) |
| June 2001 | - | $93.10 K(-19.0%) | -$298.30 K(-124.7%) |
| Mar 2001 | - | $115.00 K(>+9900.0%) | $1.21 M(-88.9%) |
| Dec 2000 | - | $0.00(-100.0%) | $10.85 M(-5.2%) |
| Sept 2000 | $11.45 M(+218.1%) | -$506.40 K(-131.7%) | $11.45 M(-4.2%) |
| June 2000 | - | $1.60 M(-83.6%) | $11.96 M(+15.4%) |
| Mar 2000 | - | $9.76 M(+1526.7%) | $10.36 M(+1626.7%) |
| Dec 1999 | - | $600.00 K | $600.00 K |
| Sept 1999 | $3.60 M(+86.3%) | - | - |
| Sept 1998 | $1.93 M(+63.9%) | - | - |
| Sept 1997 | $1.18 M(-25.1%) | - | - |
| Sept 1996 | $1.57 M | - | - |
FAQ
- What is Imunon annual cash flow from financing activities?
- What is the all time high annual CFF for Imunon?
- What is Imunon annual CFF year-on-year change?
- What is Imunon quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Imunon?
- What is Imunon quarterly CFF year-on-year change?
- What is Imunon TTM cash flow from financing activities?
- What is the all time high TTM CFF for Imunon?
- What is Imunon TTM CFF year-on-year change?
What is Imunon annual cash flow from financing activities?
The current annual CFF of IMNN is -$3.64 M
What is the all time high annual CFF for Imunon?
Imunon all-time high annual cash flow from financing activities is $54.77 M
What is Imunon annual CFF year-on-year change?
Over the past year, IMNN annual cash flow from financing activities has changed by -$10.36 M (-154.12%)
What is Imunon quarterly cash flow from financing activities?
The current quarterly CFF of IMNN is $9.06 M
What is the all time high quarterly CFF for Imunon?
Imunon all-time high quarterly cash flow from financing activities is $40.46 M
What is Imunon quarterly CFF year-on-year change?
Over the past year, IMNN quarterly cash flow from financing activities has changed by +$8.99 M (+11475.61%)
What is Imunon TTM cash flow from financing activities?
The current TTM CFF of IMNN is $9.09 M
What is the all time high TTM CFF for Imunon?
Imunon all-time high TTM cash flow from financing activities is $57.33 M
What is Imunon TTM CFF year-on-year change?
Over the past year, IMNN TTM cash flow from financing activities has changed by +$12.32 M (+382.30%)